Search

everythinglearnresearchcommunity

for

Search:↓

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

KAP-depleted hair causes less immune response and is more biocompatible for implants.

SCD1 is crucial for skin health and overall energy balance.

Obesity and BMI don't differ among PCOS types, but teens should learn about long-term health risks.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Systematic symptom assessment helps prioritize care for children undergoing cancer treatment.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Liposuction and fat grafting safely improve back muscle definition and body contour.

Altering SSAT affects fat metabolism and body fat in mice.